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Abstract 
 Heidi Shaffer, OTR/L, MSM, CLT-LANA at MultiCare-Gig Harbor was interested in 
how early intervention, namely intervening at Stage 0, related to better outcomes for oncology 
patients at risk of lymphedema. This question was developed from a desire to follow-up prior 
student research relating to the usefulness of the LDEX in lymphedema management, however 
current literature did not indicate the LDEX as an early intervention method. Although the 
authors did not exclude other types of cancer, the research only reflected breast cancer outcomes. 
Overall, strong evidence was found that exercise is not contraindicated for clients at risk of 
breast cancer related lymphedema (BCRL). There was strong evidence endorsing 
implementation of surveillance models to increase early detection and early intervention of 
BCRL. There was strong evidence that compression sleeves and decongestive therapy were 
effective in treating BCRL. There was moderate evidence to suggest that exercise and early 
intervention helped prevent the progression of BCRL. There was no evidence to the authors’ 
knowledge that surveillance methods were contraindicated for clients at risk of lymphedema. 
Additionally, there was some evidence that treating lymphedema at a subclinical stage reduces 
treatment time and inhibits the progression of lymphedema. In conclusion, surveillance methods 
coupled with early intervention could be recommended by the authors to help prevent the 
progression of lymphedema. These recommendations, if followed, may lead to reduced overall 
healthcare costs and maintain a high quality of life for oncology patients.   
 Knowledge translation was conducted to support the dissemination of our findings. Our 
knowledge translation included submitting an abstract to the International Lymphoedema 
Framework Conference in the Netherlands. The authors created and proposed a template to track 
outcomes of current and upcoming lymphedema clients. A PowerPoint was created and provided 
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to Shaffer’s supervisor, Sherri Olsen OTD, MBA synthesizing our findings. The authors then had 
an informed conversation with Olsen about their findings and the realistic application and 
implementation of the findings into practice. The authors’ hope was that Olsen would 
disseminate the information to a wider audience, specifically, providers who are responsible for 
referring clients at risk of lymphedema to a lymphedema specialist, and other lymphedema 
specialists who may benefit from this research. Future recommendations include synthesizing 
outcome data collected by lymphedema specialists at MultiCare and further investigation of the 
support systems for clients at risk of lymphedema.  
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Executive Summary  
This one-year effort began by collaboratively creating a practice question with 
Heidi Shaffer, OTR/L, MSM, CLT-LANA of MultiCare in Gig Harbor, Washington. 
Shaffer was interested in determining the extent to which early intervention impacts 
outcomes for oncology patients at risk of lymphedema. The question arose from Shaffer’s 
desire to increase her preventive care caseload. After an extensive literature search, the 
author’s conclusions were that compression garments were supported in early intervention 
to stop the progression of lymphedema. Additionally, neither exercise nor stretching were 
contraindicated for those with or at risk of lymphedema, and there was strong evidence to 
support surveillance methods as an approach to preventing the progression of lymphedema. 
Furthermore, there was some research surrounding the negative impact the fear of 
developing lymphedema has on a client’s quality of life. The implications of our findings 
varied for consumers, practitioners, and researchers. For consumers, it is important to note 
that exercise and movement do not increase the risk of lymphedema and know that the fear 
of developing lymphedema may impact function more than physical limitations as a result 
of progressing lymphedema. Future research should include quality of life measures for 
clients with lymphedema as well as retrospective information regarding how the clients felt 
about their intervention. Further research needs to be done on lymphedema related to other 
types of cancer and where it impacts the lower extremities. The implications for 
practitioners include referring clients at risk of lymphedema to a lymphedema specialist for 
preventive care and knowing that exercise is not contraindicated for those at risk of 
lymphedema. Additionally, practitioners should consider the emotional and psychological 
aspects of lymphedema during their interventions, of particular focus to occupational 
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therapy practitioners, but also applicable to any practitioner interacting with clients at risk 
of lymphedema. Knowledge translation activities included 1) an abstract submission to the 
International Lymphedema Framework conference, 2) creating a potential template for 
tracking client outcomes, and 3) a presentation to Shaffer’s supervisor. The main outcome 
of our knowledge translation activities was a consequence of our meeting with Shaffer’s 
supervisor. This consisted of immediate feedback following our presentation as well as an 
outcomes survey to be completed at a later time. The feedback from her consisted of her 
stated plan to speak to an oncologist she knows to refer for prevention care at a higher rate 
than most, discussion of plans for sharing the PowerPoint, and exploration of novel ideas 
for the dissemination of information to lymphedema patients within the MultiCare system.   
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Final CAT Paper, Revised 
Focused Question: 
 To what extent does early intervention relate to better outcomes for oncology patients at 
risk of lymphedema? 
  
Collaborating Occupational Therapy Practitioner: 
 Heidi Shaffer, OTR/L, MSM, CLT-LANA 
  
Prepared By: 
 Claire Brummet, Nicole Chang, and Kayleigh Odgear, OTS 
 
  
Chair: 
 Jennifer Pitonyak, PhD, OTR/L, SCFES  
  
Course Mentor: 
 George Tomlin, PhD, OTR/L, FAOTA 
  
Date Review Completed: 
 5/05/18 
  
Clinical Scenario: 
Heidi was interested in learning more about early intervention of lymphedema and how it 
impacts a client’s prognosis and the progression. Early intervention was defined as 
having subclinical lymphedema or Stage 1 lymphedema at the start of treatment. 
Furthermore, she was also interested in increasing her prevention caseload to help 
reduce patient financial burden and monitor lymphedema progression. 
  
Review Process 
Procedures for the selection and appraisal of articles 
Inclusion Criteria: 
 Oncology client or patient, any age, gender, and race, lymphedema measures taken 
(circumferential, volumetric, perometry, bioimpedance), Articles in English (journal 
translations allowed), any year of publication  
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Exclusion Criteria: 
 Bilateral lymphedema, vascular related lymphedema, treatment started after Stage 3 
lymphedema 
  
Search Strategy 
Categories Key Search Terms 
Patient/Client Population  Oncology clients/patients at risk of lymphedema  
Intervention (Assessment)  Early intervention (patient education and 
physical modalities) initiated by early detection 
practices  
Comparison  Current standards of practice  
Outcomes  Stage of lymphedema, quality of life (via 
questionnaire), pain, UE function (ADL 
performance, A/PROM, strength), risk factors      
  
Databases and Sites Searched 
 PubMed, CINAHL, and MEDLINE (EBSCO)   
  
  
  
Quality Control/Review Process: 
 
Claire:   
 Scan abstract for applicability to research question and investigate full article if abstract 
does not provide enough information to determine applicability to the research question. 
Created and managed database in Excel for article tracking and citation follow up. 
 
Nicole: 
 Scan article to verify our inclusion criteria is met and no exclusion criteria present.  
Find research question in article and read article once to understand it broadly. Read 
again to pull out main themes. 
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Observe how themes are changing as time progresses and as articles are found.  
 
Kayleigh: 
 Input chosen articles into the CAT table as well as organized and formatted the CAT 
table. 
 
Results of Search 
  
Table 1. Search Strategy of databases. 
Search Terms Date Database Initial 
Hits 
Articles 
Excluded 
Total 
Selected for 
Review 
Lymphedema and 
early intervention  
10/10/17 
4:17pm 
 PubMed 
 
 87 65  22 
Lymphedema and 
early intervention  
10/22/17 
6:25pm 
 CINAHL  26  22 
(2 duplicates)  
 4 
Lymphedema and 
early intervention  
 
11/03/17 
6:57pm 
MedLine 
(EBSCO) 
43  41 
(16 duplicates) 
 
2 
Lymphedema and 
early intervention  
 
11/14/17 
9:28am 
Health Source: 
Nursing/Acade
mic Ed 
(EBSCO) 
6 6 
(4 duplicates) 
0 
Lymphedema and 
early intervention  
11/14/17 
9:37am 
 
PEDro 5 5 
(4 duplicates) 
0 
Lymphedema AND 
intervention AND 
early AND oncology 
11/4/17 
9:41am 
 
 
PubMed 317 315 
(12 duplicates) 
2 
 Lymphedema and 
early intervention  
 
01/19/18 
3:15pm 
 PubMed 
 
90 89 
(87 duplicates) 
1 
Total number of articles used in review from database searches = 31 
 
 
 
EMERGING OPPORTUNITIES: LYMPHEDEMA                                                                         9 
 
Table 2. Articles from citation tracking. 
Article Date Database Initial Hits Articles 
Excluded 
Total 
Selected for 
Review 
 *n/a as of 11/14/17 
In progress  
          
Total number of articles used in review from citation tracking = 0 
  
Table 3. Articles from reference tracking. 
Article Date Articles Referenced Articles 
Excluded 
Total Selected 
for Review 
Stout, N. L., Binkley, J. 
M., Schmitz, K. H., 
Andrews, K., Hayes, 
S.C., Campbell, K. L., 
...Smith, R. A. (2012). A 
prospective surveillance 
model for rehabilitation 
for women with breast 
cancer. Cancer, 118, 
2191-2200. 
doi:10.1002/cncr.27476  
   
11/04/17 
  
119 
  
117 
 
2 
Fu, M. R., Deng, J., & 
Armer, J. M. (2014). 
Putting evidence into 
practice: Cancer-related 
lymphedema. Clinical 
Journal of Oncology 
Nursing, 18, 68-79. 
doi:10.1188/14.cjon.s3.68
-79 
 
01/18/19 
 
87 
 
86 
 
1 
Total number of articles used in review from reference tracking = 3 
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Table 3. Articles from chair recommendations. 
Article Date Total Selected 
for Review 
Maher, C., & Mendonca, R. J. 
(2018). Impact of an activity-
based program on health, quality 
of life, and occupational 
performance of women 
diagnosed with cancer. AJOT, 
72. 
doi: 10.5014/ajot.2018.023663 
3/1/2018 1 
Total number of articles used in review from chair 
recommendations = 1 
 
Total number of articles used in review from database searches = 31 
Total number of articles used in review from citation tracking = 0 
Total number of articles used in review from reference tracking = 3 
Total number of articles used in review from UPS Master’s Thesis = 0 
Total number of articles used in review from chair recommendations = 1 
Total number of articles used in CAT = 35 
 
Summary of Study Designs of Articles Selected for the CAT Table 
  
Pyramid 
Side 
Study Design/Methodology of Selected 
Articles 
Number of 
Articles 
Selected 
Experimental 3 Meta-Analyses of Experimental Trials 
5 Individual Randomized Controlled Trials 
1 Controlled Clinical Trials 
0 Single Subject Studies 
  
 9 
Outcome 0 Meta-Analyses of Related Outcome Studies 
0 Individual Quasi-Experimental Studies 
3 Case-Control Studies 
7 One Group Pre-Post Studies 
  
 10 
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Qualitative ___Meta-Syntheses of Related Qualitative 
Studies 
___Small Group Qualitative Studies 
___brief vs prolonged engagement with    
participants 
___triangulation of data (multiple sources) 
___interpretation (peer & member-checking) 
___a posteriori (exploratory) vs a priori 
(confirmatory) interpretive scheme 
___Qualitative Study on a Single Person 
  
 0 
Descriptive 1 Systematic Reviews of Related Descriptive 
Studies 
4 Association, Correlational Studies 
1 Multiple Case Studies (Series), Normative                            
Studies 
0 Individual Case Studies 
  
 6 
Comments: 10 articles were not classifiable on the pyramid because 
of the nature of the studies (cost analyses, literature reviews and 
prospective models).  
  
  
  
  
AOTA Levels 
I- 9 
II- 5 
III- 7 
IV- 4 
V- 10 
  
TOTAL = 
25 + 10 = 
35 
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Table Summarizing QUANTITATIVE Articles 
Quantitative Articles 
Author 
Year 
Journal 
Country 
Study 
Objectives 
Study 
Design/ 
Level of 
Evidence 
 
Participants 
 
Interventions & 
Outcome 
Measures 
Summary of 
Results 
Study 
Limitations 
Outcome: Limb Volume Change 
Torres Lacomba 
et al., 
 
2010, 
 
BMJ, 
 
Spain 
To determine the 
effectiveness of 
early 
physiotherapy in 
↓ risk of 2˚ LY 
post BC surgery 
RCT, single 
blinded 
Level I 
E2 
Pedro: 8/10 
N= 116 females 
TG= 59 
CG= 57 
 
I= ALND, recruited 
between May 2005 
& June 2007 
 
E= w/out ALND, 
w/bilateral BC, 
systemic disease, 
locoregional 
recurrence or those 
w/contraindications 
to physiotherapy 
Tx= 3 weeks, 3x/week. 
Tx carried out by one 
physiotherapist 
 
TG : Education, MLD, 
scar massage, stretching 
& shoulder exercises 
 
CG : Education only 
 
O= Follow-up 
measurements @ 4 
weeks, 3, 6, & 12 
months post surgery 
 
 Incidence of 2˚ LY (≥ 
2cm ↑ in CM) measured 
by blinded therapist 
TG had 4 cases of 2˚ 
LY   
CG had 14 cases of 
2˚ LY (p < .05) 
 
@ 12-month follow-
up, CG arm volume 
in affected arm was 
on average 5.1% > 
unaffected arm. TG 
volume of affected 
arm was only 1.6% > 
unaffected arm (p < 
.05) 
 
2˚ LY developed 4x 
faster in CG 
compared to TG 
 
Risk factors between 
groups were similar, 
BMI was > in TG 
Duration of follow-up 
is only one year post 
surgery 
 
Recruited patients from 
only one hospital 
 
Chose a specific dx 
criterion, other criterion 
methods may have 
resulted in more/fewer 
cases of LY 
 
No demographic info 
about patients 
Anderson et al., 
 
2012, 
 
Jnl Cancer 
Surviv, 
 
US 
To determine the 
effect of an 
exercise program 
on QOL, physical 
function & arm 
volume in non-
metastatic BC 
RCT, single 
blind study 
Level I 
E2 
Pedro: 7/10 
N= 104 adult 
females, 32-82 
years  
TG= 52 
CG=52  
I= Dx of stage 1-3 
BC w/ALND or 
SLND, no previous 
Tx= 4-12 weeks post-
surgery 
TG: RESTORE 
program w/LY 
prevention module, 
delivered by LY 
specialist (OT or PT). 
Included instruction & 
82 patients completed 
RESTORE program 
(TG=43, CG=39) 
28% were classified 
as obese 
Mean arm volume 
change @ 18 months 
was 33.5ml for TG, 
Used a combination of 
tx: strength training, 
compression, LY 
prevention exercises 
 
Those in TG had > 
contact w/health care 
providers 
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history of BC, ≥ 18 
years of age, living 
w/in 30 miles of 
study site, able to 
participate in 
moderate exercise 
program 
 
E= Homebound, 
exercise 
contraindicated, 
dependent upon 
walker or 
wheelchair for 
mobility, Dx 
dementia, peripheral 
artery disease, 
unstable angina, 
cardiac 
disturbances, 
chronic disease 
care for limb, 
awareness of LY, 1 
month follow-up. Given 
compression garment, 2 
exercise sessions per 
week (5 min warmup, 
30 min aerobic, 20 min 
U&L body, 10 min 
stretching) for 3 
months. Months 4-6 
could be home based & 
1x/week, months 7-12 
no exercise required 
 
CG: Given info about 
LY, prevention 
exercises, quarterly 
newsletter about diet & 
nutrition 
 
O= Limb volume via 
VD assessed @ 
baseline, 3, 6, 9, 12 & 
18 months post-surgery. 
Health related QOL 
assessed w/Functional 
Assessment of Cancer 
Therapy-Breast Cancer 
at baseline 15 months 
& 60.4ml in CG (p < 
.05) 
 
QOL scores were not 
statistically different 
between groups (p > 
.05) 
 
Provides evidence for 
benefit & safety of 
exercise programs & 
do not ↑risk of LY 
 
 
 
 
Larger standard error in 
arm volume 
measurements, made 
difference between 
groups not statistically 
significant 
 
22 patients dropped out 
(TG=9, CG=13) 
Box et al., 
 
2002, 
 
Breast Cancer 
Res & Treat, 
 
AUS 
To examine the 
effects of early 
intervention on 
progression & 
severity in 
patients w/BCRL 
RCT 
Level I 
E2 
Pedro: 6/10 
N= 65 females 
Mean age = 56.06 
years 
 
I= ALND or 
modified radical 
mastectomy 
between July 1st 
1996 to June 30th 
1997 
 
Tx=  
TG: Physiotherapy 
management care plan 
 
CG: Tx condition was 
not specified 
 
O= CM & VD. 
Measures were taken 
pre-op, 5th day post-op, 
1, 3, 6, 12 and 24 
TG had an incidence 
rate of 11% for 2˚ 
LY, while CG had an 
incidence rate of 30%  
 
Patient arm volume 
still ↑ despite tx 
 
Trend for ↑ risk for 
LY w/a > BMI 
 
Size of TG & CG were 
not given 
 
Details of the 
physiotherapy 
management plan & 
CG tx were not 
provided 
 
Settings of txs & length 
of tx were not given 
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E= Confused mental 
state, reconstructive 
surgery, lived 
beyond 50km from 
hospital, refused 
random allocation, 
unable to obtain 
informed consent & 
pre-data 
months post-op by a 
blinded physiotherapist 
  
 
Oliveria et al., 
 
2014, 
 
Physiotherapy 
Theory & 
Practice, 
 
Brazil 
To compare MLD 
& active exercise 
on post-op 
complications in 
women w/BC 
Non-
randomized 
controlled 
clinical trial 
Level II 
E3 
Pedro: 5/10 
N= 89 females 
Exercise group= 46 
MLD group= 43 
 
I= Unilateral BC 
w/ALND between 
October 2006 & 
July 2011 
 
E= Immediate 
breast 
reconstruction, 
difference in UE 
CM > 2cm pre-
surgery, motor 
deficit or infection 
in UE & pre-op 
radiotherapy 
Tx=  
Exercise group: Given 
educational strategy & 
40-minute group 
exercise sessions 
2x/week for 30 days. 19 
exercises were 
performed under 
supervision of physical 
therapist 
 
MLD group: Given 
educational strategy & 
40-minute individual 
MLD 2x/week for 30 
days performed by 3 
experienced physical 
therapists 
 
O= CM (↑ by 2cm or 
more = LY 
development), Shoulder 
ROM measurements 
taken pre-op & 60 days 
post-surgery 
There was no 
significant difference 
between shoulder 
ROM & CM pre-op 
& post-op 
measurements 
between groups 
 
Exercise is not 
contraindicated in 
patients at risk for 
developing LY 
 
 
 
No blinding of 
participants or 
therapists 
 
Type of ROM was not 
specified 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Akita et al., 
 
2017, 
 
Jnl Amer Soc 
Plastic Surg, 
To investigate 
early changes in 
LY using 
indocyanine green 
lymphography & 
propose a new 
Prospective 
cohort study 
Level III 
O4 
Pedro: 3/6 
 
N= 190 females 
 
I= consecutive 1˚ 
BC patients who 
underwent surgery, 
included SLND or 
Tx= Injection of 
indocyanine green 
subcutaneously into 
affected UE. One hour 
post injection, 
circumferential 
35 patients needed 
compression therapy, 
11 of those patients 
improved while 24 
needed persistent 
compression therapy 
Out of 390 patients, 
only 190 were followed 
up for a full year 
 
Mean follow-up was 
short (20 months) 
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Japan 
strategy for early 
Dx & tx of BCRL 
ALND from July 
2013 to July 2014 
 
E= Iodine allergy, 
pregnancy, 
recurrence 
following previous 
BC, & psychiatric 
disorders 
fluorescent images of 
lymphatic drainage 
channels obtained. 
Images classified into 
patterns: linear, splash, 
stardust, diffuse or no 
flow 
L-Dex value ↑ of 10% 
or > is a significant 
limb volume ↑  
 
Those w/splash pattern 
followed w/no tx. 
Stardust, diffuse or no 
flow received skin care, 
exercise, elevation and 
compression sleeve.  
 
O= Changes in limb 
volume 
 
Measurements taken 
pre-op & follow-up 
measurements 1, 3, & 
every 3 months 
thereafter until 12 
months post-surgery 
 
This method of 
measurement can be 
applied to bilateral 
cases, low cost, less 
cumbersome 
 
Detected lymphatic 
dysfunction in 21 out 
of 35 patients before 
any limb volume 
change was visible 
 
Risk factors found 
were age, BMI, 
radiation therapy, 
ALND & docetaxel 
 
 
resulting in a net 
incidence rate that 
could not be fixed 
 
 
 
 
 
 
Jang et al., 
 
2015, 
 
PLOS One, 
 
Korea 
To evaluate the 
effects of arm 
swelling duration 
on shoulder 
pathology in 
patients w/BCRL 
Cross-
sectional 
study 
Level IV 
D2 
Pedro: 2/3 
N= 47 women 
 
I= Unilateral LY, 
Dx w/BCRL & free 
of cancer at time of 
study 
 
E= Bilateral LY, 
lymphangitis, skin 
disease, 
inflammatory 
shoulder arthritis, 
previous shoulder 
Tx= Patients underwent 
musculoskeletal 
examination & 
ultrasound of shoulder 
region & shoulder 
ROM. All were done by 
a certified Korean 
physiatrist, then 
confirmed by a second 
physiatrist 
Arm measurements 
were also taken 
 
41/47 (87.2%) of 
patients were found 
to have shoulder 
abnormalities 
 
Those w/ 
supraspinatus tendon 
tear were found to 
have a significantly 
longer duration of LY 
(p < .05) 
 
Participants were taken 
from one hospital 
 
Degenerative cause of 
shoulder pathology 
could have not been 
related to LY 
 
Duration of LY was 
determined by patient’s 
self-report of 
symptoms. It is unclear 
when LY was Dx 
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trauma, or previous 
shoulder surgery  
O= CM, comparison of 
duration of LY 
according to shoulder 
pathology 
The pathology of 
shoulder pain is 
related to the duration 
of LY. Duration of 
LY influences the 
pathology, but is not 
correlated with 
symptoms 
 
Type of ROM 
measurements were not 
provided 
Outcome: ROM, Strength & Limb Volume Change 
Kilbreath et al., 
 
2012, 
 
Breast Cancer 
Res & Treat, 
 
AUS  
To determine 
whether an 
exercise program 
reduces upper 
limb impairments 
in women treated 
for early BC 
RCT, double 
blinded 
Level I 
E2 
Pedro: 9/10 
N= 160 female 
participants, 24-82 
years  
TG:  
ALND= 50 
SLND= 31 
 
CG:  
ALND= 46 
SLND= 33 
I= Undergone 
surgery for stage 1-
3 BC, either SLND 
or ALND, could 
communicate in 
English, attend tx & 
follow-up visits 
 
E= History of LY, 
bilateral BC, 
metastatic BC, pre-
existing arm 
impairments 
Tx= 4-6 weeks post-op, 
for 8 weeks 
TG : Seen weekly, 
participated in 
resistance training, 
passive stretching & 
given home program. 3 
stretches to perform 
daily, hold for 5-15 
min. Resistance 
training = 2 sets, 8-15 
reps of each exercise (# 
of exercises not given) 
 
CG : No exercises 
given, education only. 
Assessed fortnighlty for 
LY. If LY, tx was 
compression garment 
 
All women received 
post op care including : 
literature about 
prevention, seen by 
breast nurse or 
physiotherapist or OT, 
patients given info 
about post-op exercises 
 
O= Pre/post tx & 6 
month follow-up 
Changes in symptoms 
from self-report QOL 
survey were not 
significant between 
groups 
 
Shoulder ROM in 
affected arm 
increased 
significantly for TG 
compared to CG 
immediately post 
intervention (for 
abduction & flexion, 
p < .05) 
 
Shoulder strength 
increased 
significantly  in TG 
compared to CG 
immediately post 
intervention (for 
abductors & flexors, 
p < .05) 
 
No significant 
changes in LY 
occurred in either 
group (p > .05) 
 
 
1˚ outcome measure 
relies on self-report  
 
CG likely exposed to 
exercise 
recommendations 
during post-op hospital 
stay 
 
No follow-up before 6 
months 
 
Participants were 
younger on average 
than women Dx w/BC  
 
Type of ROM 
measurements were not 
specified 
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measurements taken by 
blinded researcher. 
Self-report QOL 
survey, shoulder ROM, 
shoulder muscle 
strength, CM 
 
 
Ammitzboll et al., 
 
2017, 
 
ACTA 
Oncologica, 
 
Denmark 
To determine if 
progressive 
strength training 
is feasible & safe 
for one year post 
BC to inform 
future RCT 
Prospective 
pilot trial 
Level III 
O4 
Pedro: 3/6 
 
N= 8 female BC 
patients recruited 
August 2015 
 
I= between ages 18-
75, ALND for 1˚ 
unilateral BC, 
transportation to 
hospital, & 
physically/mentally 
able to participate in 
exercise 
 
E= previous ALND 
(either side), 1˚ 
breast 
reconstruction, 
metastatic disease, 
& history of LY 
Tx= Individualized 
exercise programs 
based on 7 rep max. 
Took place in 
Physiotheraphy Dept @ 
Herlev hospital & 
supervised by 
physiotherapists.  
Regime had 5 modules, 
each being 4 weeks in 
duration. 6 exercises, 3 
sets per module. 
Exercised 2x @ 
hospital, 1x @ clients 
choice per wk. After 20 
weeks, patient 
exercised on their own 
Symptoms recorded 
weekly.  Arm volume 
@ 12 & 20 weeks. 
Symptoms lasting 2+ 
weeks, extra arm 
measurements taken. 
BMI @ baseline, 
dynamic strength @ 
baseline, 12, 20 & 50 
weeks, isometric 
strength @ baseline, 20 
& 50 weeks, hand 
strength & shoulder 
PROM @ baseline & 
50 weeks, questionnaire 
@ baseline, 20 & 50 
weeks 
1 patient had 5% ↑ in 
interlimb volume 
difference @ 50 week 
follow-up. 3 had ↑ 
interlimb volume 
difference & 
symptoms during 
program, but @ 50 
week follow-up, 
returned to baseline 
 
Dynamic/isometric 
muscle strength: all 
showed ↑ @ 50 week 
follow-up  
 
Grip strength: ↓ 
bilaterally @ 50 week 
follow-up 
 
Shoulder PROM: 
Shoulder abd seemed 
most restricted post-
surgery 
 
Exercise program 
was found to be 
feasible & had high 
satisfaction, 
adherence was 
moderate. Muscle 
strength gains were 
greatest during 
supervised sessions 
Drop-out rate of 25% 
(n=2) 
 
Focused only on one 
component of rehab 
(strength) 
 
Small sample size 
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O= feasibility 
outcomes, VD, BMI, 
Dynamic muscle 
strength, isometric 
muscle strength, hand 
grip strength & 
shoulder PROM, 
questionnaire data 
Springer et al., 
 
2010, 
 
Breast Cancer 
Res & Treat, 
 
US 
To examine the 
extent & time 
course of UE 
impairment & 
dysfunction in 
women being 
treated for BC 
Prospective 
observational 
study 
Level III 
O4 
Pedro: 3/6 
 
N= 94 participants 
 
I= Women dx 
w/unilateral stage 1-
3 BC between 2001 
and 2006 
 
E= Male, < 18 years 
of age, history of 
BC, bilateral BC, 
injury/surgery 
affected UE 
Tx= Evaluated by 
physical therapist at 
baseline & follow-up 
appointment 
Instructed on post-op 
AROM exercise 
program & education 
on LY. If patient Dx 
w/LY, tx was initiated. 
No movement 
restrictions were given 
 
O= Measurements 
taken pre-op, 1, 3-6 
months post-op & 12 
months+ post-op 
Shoulder AROM 
(flexion, abduction, 
internal rotation, 
external rotation), 
manual muscle testing, 
UE volume 
Shoulder AROM & 
strength ↑ after 1 
month post-op 
 
@ 12 months, 92% 
reported no or slight 
limitations 
performing hard UE 
functional tasks 
 
Limb volume ↑ over 
course of follow-up, 
however differences 
between the affected 
& unaffected limbs 
was insignificant, 
thought to be due to 
weight gain 
 
Significant difference 
found between those 
w/subclinical LY & 
those w/out (p < .05) 
All subjects from a 
military 
background/association 
 
Mean age was younger 
than most studies 
 
Many sought out after 
care closer to home, 
resulting in less patients 
@ follow-up & varying 
tx from other clinics 
 
 
Stout Gergich et 
al., 
 
2008, 
 
Cancer, 
 
US 
To investigate the 
efficacy of a 
surveillance 
method for early 
Dx & tx of 
subclinical LY 
Case control, 
observational 
study 
Level II 
O3 
Pedro: 4/6 
N= 196 patients 
TG= 43 
w/subclinical LY 
(volume ↑ > 3%), 
aged 34-82 years  
 
CG= 43 w/out LY, 
aged 33-81 years  
Tx= Upon Dx of LY, 
patient given 
compression garment to 
wear daily for 4 weeks. 
No activity limitations 
were given 
 
Mean ↑ of volume 
change in TG was 83 
mL and 2.7 mL in 
CG 
 
TG had > UE volume 
than CG @ beginning 
of intervention 
Perometer used to Dx 
LY may not be 
financially available 
 
Unable to control BC 
related side effects 
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I= Newly Dx 
w/unilateral early 
stage BC 
 
E= History of BC, 
bilateral BC, prior 
trauma/surgery on 
UE 
O= Bilateral AROM, 
strength & UE volume 
were assessed pre-op, 1, 
3, 6, 9, 12 & 18 months 
post-op 
 
Follow-up after 
intervention, limb 
volume ↓ was 46 mL 
w/activity related 
garment wear, 
compared to 2.3 mL 
↓ in CG 
Setting of tx not 
indicated 
 
Tx for CG was not 
specified 
 
 
 
 
 
Outcome: QOL 
Thakur et al.,  
 
2016, 
 
Indian Jrnl of 
Physiotherapy & 
OT, 
 
India 
To determine 
effectiveness of 
early 
physiotherapy to 
reduce risk of 
developing 2˚ LY 
RCT 
Level I 
E2 
Pedro: 5/10 
 
N= 20 females 
TG= 10 
CG= 10 
 
I= Above age 18, 
unilateral BC 
surgery w/ALND 
 
E= 
Recurrence/relapse 
of BC, bilateral BC, 
untreated infection, 
heart disease, renal 
disease, deep vein 
thrombosis, & any 
other 
physiotherapeutic 
contraindications 
Tx=  
TG: Given educational 
strategy & early 
physiotherapy 
intervention (MLD, UE 
stretching exercises, 
active/active assisted 
shoulder exercises, 
proprioceptive 
neuromuscular 
facilitation exercises) 
CG: Given only 
educational strategy 
 
Both programs lasted 3 
weeks w/3 visits per 
week 
 
O= QOL & VD 
Mean QOL scores 
were significantly 
better for the TG than 
the CG (p < .05) 
 
Mean VD 
measurements were 
significantly > for 
CG post-tx (p < .05) 
 
Intervention w/early 
physiotherapy & 
education was 
significantly more 
effective @ reducing 
risk for developing 2˚ 
LY compared to just 
education 
Small sample size 
 
Details regarding 
educational materials 
were not provided 
 
Information about what 
QOL survey used was 
not given 
 
Very brief results 
section, only given 
tables w/no explanation 
 
No blinding of subjects 
or assessors 
Gordon et al.,  
 
2005, 
 
Breast Canc Res 
& Treat, 
 
AUS 
To assess changes 
in health related 
QOL & upper 
body disability 
over time  
Longitudinal 
Quasi-
experimental 
design 
Level II 
O3 
Pedro: 4/6 
N= 275 women 
TG: DAART 
program = 36 
STRETCH program 
= 31 
CG = 208 
 
I= 1˚ unilateral BC, 
spoke English, & 
were between 25-74 
Tx=  
TG: DAART (home-
based physiotherapy) or 
STRETCH (group-
based & psychosocial 
tx) program. The goal 
of the programs was to 
↑ UE strength & 
provide support 
 
DAART participants 
showed clinically 
significant 
improvements in UE 
function & health 
related QOL 
 
There was minimal 
change in QOL & UE 
CG was only available 
for measures taken at 6 
& 12 months 
 
Selection bias of TG 
because they were 
generally healthier than 
others w/BC, maybe 
impacting 
generalizability 
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w/no cognitive 
impairments 
 
E= Too ill, did not 
understand English, 
or previously 
attended one of the 
intervention 
programs 
 
Between May 2002 
& July 2003 
CG: Did not receive 
support group tx 
 
O= Health related QOL 
& UE strength. 
Measures were taken at 
pre/post tx, 6 & 12 
months from Dx 
 
 
function in 
STRETCH group 
 
Early intervention 
may expedite 
recovery & enhance 
QOL 
 
 
 
Only relevant to those 
w/unilateral BC 
 
Very little information 
was given about what 
the TG & CG were 
given as tx 
 
Groups were not similar 
at baseline 
 
Maher & 
Mendonca, 
 
2018, 
 
AJOT, 
 
USA 
To determine 
impact of a 1-
week activity 
program on 
health, QOL & 
occupational 
performance in 
women Dx 
w/cancer.  
One-group 
Pre-Post test 
Level III 
 O4 
Pedro: 3/6 
N= 71 females Dx 
w/cancer 
 
I= Women 
w/cancer, aged 21 
or older, & 
clearance from 
physician 
 
E= Not specified 
Tx= 5 day long activity 
camp from 9 am to 1pm 
addressing QOL, 
health, well-being and 
occupational 
performance. 4 classes 
were done each day and 
included activities such 
as Tai Chi, dance, 
poetry, scrapbooking, 
meditation, yoga, 
gardening, cooking, and 
nutrition. Classes were 
taught by occupational 
therapists and 
occupational therapy 
students 
 
O= 3 assessments were 
administered: 36 item 
Short Form Health 
Survey, World Health 
Organization QOL 
Brief Survey, and the 
COPM. COPM was 
administered on day 1, 
5 and @ 6 week follow 
up. QOL and health 
A significant 
difference was found 
on the QOL Social 
Relationships 
subscale (p = .002, 
w/moderate effect 
size, dz = 0.37). No 
other subscales had 
significant differences 
@ posttest 
 
Mental Health subscale 
on the health survey did 
have a moderate effect 
size, but was not 
significantly different 
(dz = 0.28) 
 
Results of COPM were 
statistically significant 
between pre-posttest, 
pre & follow up, & post 
to follow up (p < .05) 
implying improved 
occupational 
functioning 
Women who had 
completed and were 
actively completing 
cancer tx were used in 
the study. 6 recruits 
were lost due to 
medical complications 
from tx 
 
All 3 assessments were 
time consuming surveys 
 
Exclusion criteria were 
not specified 
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survey were 
administered on day 1 
and @ 6 week follow 
up.                                
O’Toole et al., 
 
2015, 
 
Breast Cancer 
Res & Treat, 
 
US 
To assess the 
association 
between BCRL & 
ability to perform 
ADLs  
Prospective 
surveillance 
Level IV  
D2 
Pedro: 2/3 
 
N= 324 females 
between 2005 & 
2014. Median age@ 
Dx = 56 years  
 
I= Unilateral BC 
 
E= Bilateral breast 
surgery & 
metastatic cancer 
 
Tx= Pre-op limb 
volume measurement 
w/perometry. 
Perometry 
measurements post-op, 
after chemo/radiation, 
& every 3-7 months @ 
each visit, questionnaire 
for QOL  
 
O= RVC (BCRL 
defined as RVC↑ ≥ 
10%) 
QOL survey scores 
32% had one or more 
RVC ↑ between 5-
10% 
8% had RVC ↑ ≥ 
10% post-op.  
 
No significant 
association between 
BCRL & ability to 
perform ADLs 
 
Significant 
association between 
physical function, 
pain & fear w/ability 
to perform ADLs. ↓ 
functional scores 
were associated w/ ↑ 
fear, > pain, 
mastectomy & 
ALND (p < .05) 
↓ rate of LY in this 
cohort 
 
Their program utilizes 
early intervention 
strategies, which can 
slow LY progression. 
More severe LY may 
result in > impact on 
function 
 
Outcome: Risk Factors & Limb Volume Change 
Kaufman et al., 
 
2017, 
 
Breast Cancer 
Res & Treat, 
 
US 
To assess impact 
of early 
intervention using 
BIS as 
surveillance tool 
to detect BCRL 
Prospective 
BCRL 
surveillance 
program 
Level III 
O4 
Pedro: 4/6 
N= 206 BC patients, 
mean age of 61.  
Between August 
2010 & December 
2016 
 
High risk patients = 
ALND & regional 
node irradiation 
patients 
 
I= patients w/BC, 
undergoing BC 
surgery 
Tx= pre-op baseline L-
Dex measures, post-op 
measures @ 6 weeks, & 
3-6 month intervals.  
Subclinical BCRL 
defined as : L-Dex 
score ↑ > 10 from 
baseline. If > 10, patient 
given over the counter 
compression garment 
for 4 weeks. Patients 
underwent repeated L-
Dex measures, if no 
resolution, patients 
Overall, 9.8% of 
patients (n=21) were 
Dx w/subclinical 
BCRL. 7 of these 
were ALND patients 
& 12 were SLND 
patients 
 
Findings supported 
use of structured 
surveillance 
programs to ↓ 
morbidity of BCRL 
 
Follow-up time was 
short (25 months), 
limiting long-term 
outcomes 
 
No control group for 
comparison if LY 
would have resolved 
w/out tx   
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E= no implantable 
devices 
(pacemakers), 
pregnancy, renal 
failure, & heart 
failure 
were defined as chronic 
BCRL & sent to CDT 
 
O= L-Dex 
measurements 
Client characteristics : 
BMI, age. 
Tx characteristics : 
surgery, axillary 
management, chemo, 
radiation, & regional 
node irradiation 
Found ALND & 
regional node 
irradiation were risk 
factors for developing 
subclinical BCRL 
w/elevated BMI. 
 
 
 
 
 
 
Jammallo et al., 
 
2013, 
 
Breast Cancer 
Res Treat, 
 
US 
To assess the 
impact of pre-op 
BMI & post-op 
weight change on 
risk for LY  
Pre-Post study 
Level III 
O4 
Pedro: 3/6 
N= 787 females 
Between 2005 & 
2011 
 
I= Undergoing tx 
for 1˚ BC at their 
institution 
 
E= Bilateral breast 
surgery & 
metastatic disease 
Tx= Pre-op BMI & arm 
volume w/perometry 
was taken. LY was 
defined as RVC ↑ ≥ 
10%, occurring > 3 
months post-op 
Post-op BMI & arm 
volume w/perometry 
taken 
 
O= BMI & arm 
volume, evaluated 
every 3-8 months post-
op (depended on clients 
next visit) 
Participants w/BMI ≥ 
30 had 4.5x ↑ risk for 
developing LY 
compared to BMI < 
25 (p < .05) 
 
ALND & regional 
lymph node radiation 
were found to be risk 
factors for LY (p < 
.05) 
 
 
Authors claim LY was 
measured by perometry, 
but no data was given 
to show those 
measurements, only 
reported BMI 
 
BMI & perometry 
measurements were not 
taken during same visit 
 
Non-standardized 
measurement schedule 
was used (every 3-8 
months depending on 
clients visit) 
Soyder et al., 
 
2014, 
 
Jnl Breast Health, 
 
Turkey 
To determine 
post-op LY 
frequency & 
identify risk 
factors 
Retrospective 
study 
Level IV 
D2 
Pedro: 2/3 
N= 101 females Dx 
w/unilateral BC 
 
I= surgery to breast 
& axilla between 
January 2010 - 
March 2011 
 
E= Were not 
specified  
 
 
Tx : CM 12th months 
follow-up post surgery. 
If LY present, patient 
referred to LY tx center. 
Patient characteristics 
were taken 
 
O= CM  
Risk factors : Age, 
BMI, smoking status, 
arm dominance 
 
LY was found in 7 
patients @ 12 months 
assessment 
 
No risk factors were 
found to be 
significantly 
correlated w/LY 
development (p > 
.05), but 6 cases had 
a BMI > 25 
 
No pre-op 
measurements 
 
Exclusion criteria were 
not specified  
 
Details of tx were not 
provided 
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Applied tx factors : 
surgery type, dissected 
# lymph node, lymph 
node positivity, post-op 
seroma & infection, 
chemo or radiation, 
grade of tumor, size of 
tumor  
Applied tx factors 
that were 
significantly 
correlated w/LY 
were: axillary 
dissection or SLND, 
lymph node 
positivity, > 15 
lymph node 
dissections, radiation 
therapy & tumor size 
(p < .05) 
 
Radiation therapy & 
axillary dissection 
appear to be major 
factors that ↑ risk for 
LY 
Outcome: Prospective Surveillance Model & Cost 
Whitworth & 
Cooper,  
 
2017, 
 
Breast Jrnl, 
 
US 
To evaluate 
patient outcomes 
of a large group 
using prospective 
surveillance & 
BIS 
Prospective 
Surveillance 
Level III 
Pyramid: O4 
Pedro: 3/6 
N= 596 women at 
risk for developing 
BCRL. 
 
I= Nashville Breast 
Center, between 
April 2010 & 
November 2016. 
 
E= were not 
specified. 
Tx= Patients followed 
prospectively using a 
standard protocol 
including BCRL 
education & pre/post 
BIS measurements. If 
L-Dex measurements ↑ 
> 10 points from 
baseline (subclinical 
LY), patient given over 
the counter 
compression garment 
for 4 weeks, then L-
Dex score was 
rechecked. Median 
follow-up time was 17 
months, w/an average 
of 4 visits. 
 
Patients were 
considered high risk if 
Overall, 73 patients 
had abnormal L-Dex 
levels. 18 of these 
patients scores did 
not return to normal 
and required CDT. 
 
Patients undergoing 
ALND were more 
likely to develop an 
abnormal L-Dex 
score & unresolved 
BCRL (p < .05).  
 
This evidence 
supports the use of 
prospective 
surveillance for at 
risk patients using 
BIS to detect 
subclinical LY.  
No exclusion criteria 
were provided.  
 
Did not provide 
information on when 
follow-up visits 
occurred after surgery.  
 
Little information was 
given about the 
standard protocol used, 
education provided & 
how/where 
measurements were 
taken.  
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BMI > 25 (n= 379), 
ALND (n= 93), 
regional nodal 
irradiation (n= 17) or 
taxane chemotherapy 
(n= 163).  
Shih et al., 
 
2009, 
 
Jrnl of Clinical 
Oncol, 
 
US 
To examine the 
economic burden, 
incidence & risk 
factors of BCRL 
Regression 
Analysis 
Level II 
Pyramid: D2 
Pedro: 2/3 
 
N= 1,877 women 
W/BCRL: n= 180 
W/out BCRL: n= 
1,697. 
 
I= Women, been 
observed by 
physician for 2 
years, & ICD-9 
codes 457.0 & 
457.1 between 1997 
& 2003. 
 
E= Men, enrollees 
w/missing 
identifiers, & <27 
months of 
continuous care.  
Tx= Matched CG was 
created to compare 
costs & complications 
of BCRL.  
 
Multivariate logistic 
regression was 
performed to ascertain 
factors associated 
w/BCRL & to compare 
the rates of 
complications between 
groups.  
10% (n= 180) women 
had Dx of LY w/in 2 
years of BC tx.  
 
Significantly higher 
proportion of women 
w/BCRL underwent 
mastectomy, ALND, 
chemotherapy or 
lived in the West (p < 
.05).  
 
Incidence of BCRL ↑ 
from 9.6% in 2 year 
follow up to 12% in 4 
year follow up.  
 
15.9% of women 
w/BCRL developed 
lymphangitis & 
14.1% developed 
cellulitis, compared 
to 8.4% & 7.8% in 
CG.  
 
Total cost for tx in 
BCRL group was 
$86,707 & &64,554 
for the CG.  
 
  
Cost of BCRL was 
likely underestimated 
because costs were 
estimated at first 2 
years of BC tx, not 2 
years after LY Dx. 
 
ICD-9 codes in claims 
data were used to 
identify women. Some 
women in CG may of 
had LY, but Dx was not 
added to insurance 
claims. 
 
Participants were 
working-age women 
w/BCRL and therefor 
may not be 
generalizable to elderly 
women w/BCRL.   
Stout et al., 
 
2012, 
To compare a 
prospective model 
w/a traditional 
Perspective 
article on cost 
analysis 
I= were not 
specified 
 
Tx= Prospective model 
or traditional model 
 
The cost of treating & 
managing BCRL in 
one patient 
Does not consider 
indirect costs 
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Physical Therapy, 
 
US 
model & examine 
direct tx costs for 
each program 
Level V 
Pyramid N/A 
Pedro: N/A 
 
E= were not 
specified 
Methods for 
determining costs: 
Average retail costs 
considered for durable 
medical equipment, 
incidence data used to 
approximately newly 
Dx cases, only direct tx 
costs associated 
w/intervention were 
included. Defined direct 
tx costs, early-stage 
LY, & advanced-stage 
LY 
 
O= costs of prospective 
model & costs of 
traditional model 
w/prospective model 
per year for early-
stage LY is $636.19 
Cost of treating & 
managing advanced-
stage LY 
w/traditional model 
would be $3,124.92 
 
For 100 patients, 
prospective model 
costs range from 
$29,315.50 to 
$43,799.20 per year. 
Traditional model 
costs range from 
$32,811.66 to 
$149,996.16 per year 
per 100 patients 
 
Prospective 
surveillance is 
effective for early 
detection & tx. May ↓ 
overall health care 
costs compared to 
traditional model 
 
Upfront cost for 
prospective model 
may be a barrier to 
implementation 
Need to consider 
additional cost sensitive 
variables like time lost 
from work, ADLs, 
QOL & disability 
 
Estimated costs based 
on estimated incidence 
rates 
 
Assumed LY in patients 
in prospective model 
did not progress 
Only considered costs 
of tx for single BC 
related impairments, 
not bilateral 
 
 
 
 
  
Carlson, R., 
 
2012, 
 
Oncol Times, 
 
US 
To examine the 
evidence for 
implementing the 
prospective 
surveillance 
model into 
standard care 
Opinion  
Level V 
Pyramid N/A 
Pedro: N/A 
N/A Tx= Stout et al. (2012, 
next table entry) 
prospective surveillance 
model 
 
O= Should prospective 
surveillance model be 
implemented 
No consensus has 
been reached. The 
prospective model 
has positives & 
negatives to it, 
however there does 
need to be a more 
standardized form of 
No resources or 
references cited to back 
up authors opinions 
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care for patients 
w/BCRL 
Stout et al., 
 
2012, 
 
Cancer, 
 
US 
 
To introduce a 
prospective 
surveillance 
model of care for 
BC physical 
rehabilitation 
Prospective 
surveillance 
model 
Level V 
Pyramid N/A 
Pedro: N/A 
 
I & E= Would be 
based on a risk & 
impairment 
screening to 
determine if eligible 
for tx 
Tx= Pre-op eval & 
education 
 
Early post-op rehab: re-
eval & exercise 
program 
 
Ongoing surveillance 
 
O= feasibility of such a 
program 
 
There is a need for 
ongoing surveillance 
for those @ risk for 
LY 
 
Prospective 
surveillance model 
provides framework 
for values survivors 
indicate as important  
Little info provided on 
cost of prospective 
surveillance model 
 
No inclusion & 
exclusion criteria for 
prospective patients 
 
 
Outcome: UE Function 
Singh et al., 
 
2013, 
 
Physiotherapy, 
 
Canada 
To compare the 
effects of arm 
morbidity w/early 
physiotherapy 
intervention to an 
intervention 
w/pre-op 
education only 
Prospective 
quasi-
experimental 
prettest-
posttest 
Level II 
O3 
Pedro: 4/6 
N= 72 females 
TG= 41 
CG= 31 
 
I= Women 
receiving surgery 
for BC including 
modified radical 
mastectomy, simple 
mastectomy or 
breast conserving 
surgery. All stages 
of cancer were 
included 
 
E= Transverse 
rectus abdominis 
myocutaneous flap 
surgery at time of 
breast surgery, 
could not provide 
informed consent in 
English, or unable 
to physically engage 
in physiotherapy 
Tx=  
TG: Received 
standardized pre-op 
education & seen twice 
post-op (1 & 6 months). 
Further tx were 
provided if needed (↓ 
AROM, ↓ in strength, ↑ 
in limb girth, or poor 
posture). Focus was on 
self-management 
techniques 
(compression), scar 
tissue massage, & 
progressive shoulder 
exercises 
 
CG: Received 
standardized pre-op 
education only 
 
All education & follow-
up visits were done by 
one of two trained 
physiotherapists 
For the TG, shoulder 
AROM had returned 
close to baseline, 
while the CG post-op 
measurements were 
lower than their 
baseline 
 
At post-op, 
differences in QOL 
were not statistically 
significant in TG vs 
CG (p > .05) 
 
There was a lower 
incidence of LY in 
TG than CG, but it 
was not statistically 
significant (p = 0.19) 
 
Arm morbidity was 
lower in the TG than 
the CG but was also 
not statistically 
significant 
Duration of tx sessions 
were not given 
 
Longer follow-up may 
be needed to identify 
the true incidence of 
arm morbidity 
 
Physiotherapists 
performing follow-up 
measures were not 
blinded 
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O= Composite measure 
of arm morbidity (↓ in 
shoulder AROM ≥ 10˚) 
Presence of LY (2cm ↑ 
in UE circumference 
compared to pre-op). 
self-report 
questionnaires (UE 
function & QOL) 
 
Measurements collected 
pre-op (baseline) & 7 
months post-op for all 
participants. TG was 
assessed at 1 & 6 
months post-op 
(additional sessions 
were recorded) 
 
There needs to be 
more effective 
management to treat 
& identify UE 
impairments in those 
w/BC 
Schmitz et al., 
 
2012, 
 
Cancer, 
 
AUS 
To provide data 
for the prevalence 
of adverse effects 
in BC survivors in 
a 6-year follow-
up 
Longitudinal 
observational 
cohort study 
Level IV 
D3 
Pedro: 1/3 
 
N= 287 women 
 
I= Unilateral BC, 75 
or younger, 100km 
radius of Brisbane, 
between January & 
December 2002 
 
E= Were not 
specified 
Tx= Personal, tumor & 
treatment characteristics 
were collected by 
questionnaires. 
Functional Assessment 
of Cancer Therapy 
Breast +4 & the 
Disability of the Arm, 
Shoulder & Hand were 
given to the clients 
 
O= UE function & 
symptoms. Surveys & 
characteristics were 
measured at baseline, 6, 
12, 18 months & 6 
years follow-up.  
At 6-year follow-up, 
60% of women were 
experiencing more 
than 1 adverse tx 
effect 
 
Prevalence of most 
physical impairments 
decreased throughout 
the 6 years follow-up, 
except for LY & 
weight gain 
 
These findings lend 
merit to the proposal 
of a prospective 
surveillance for 
adverse tx effects 
 
Did not specify 
exclusion criteria 
 
Relied on patient recall 
& report of physical 
limitations 
 
It is hard to determine if 
some of the adverse 
effects were caused by 
BC tx 
 
Comorbid conditions & 
natural aging process 
need to be considered 
 
Adverse effects were 
limited to those that 
were established & 
clinically defined 
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Abbreviation Key for Quantitative Table 
ALND = axillary lymph node biopsy, A/PROM = active/passive range of motion, BC = breast cancer, BCRL = breast cancer related lymphedema, BIS = 
bioimpedance spectroscopy, BMI = body mass index, CDT = complete decongestive therapy, CG = control group, CM = circumferential measure, Dx = 
diagnosis/diagnostic, E = exclusion, I = inclusion, L-Dex = lymphedema index, LY = lymphedema, O = outcomes, QOL = quality of life, RVC = relative volume 
change, SLND = sentinel lymph node biopsy, TG = treatment group, Tx = treatment, UE = upper extremity, VD = volume displacement  
 
Table Summarizing Meta-Analyses/Meta-Syntheses/Systematic Review Articles 
  
Systematic Reviews/Meta-Analyses/Meta-Syntheses 
Author 
Year 
Journal 
Country 
Study 
Objectives 
Study 
Design/ 
Level of 
Evidence  
Number of Papers Included, 
Inclusion and Exclusion Criteria 
Interventions & 
Outcome 
Measures 
Summary of 
Results 
Study 
Limitations 
Non-Systematic Reviews 
Outcome : QOL, Dx & Tx Trends 
Sayegh et 
al., 
 
2017, 
 
Curr Breast 
Cancer Rep, 
 
US 
To discuss recent 
studies regarding 
risk factors, Dx, 
prevention 
through early 
screening & 
intervention of 
BCRL to improve 
QOL for 
survivors 
Non-
systematic 
Review 
Level V 
N/A 
N/A O= Ways to 
improve QOL for 
BCRL patient 
Recent information 
regarding Dx, tx, 
risk factors 
Dx measures: VD, 
CM, perometry & 
BIS 
Risk factors: 
regional lymph 
node radiation, 
method of surgery, 
high BMI, weight 
fluctuations, 
subclinical edema 
& cellulitis 
 
Txs: regular 
screening using 
various methods 
(VD, CM, 
perometry, BIS), 
Suggested the need 
to improve QOL for 
survivors, however 
did not recommend 
any ways to do that 
 
Out of 94 
references, only 
provided basic 
background 
information on 7 of 
them 
 
 
 
 
 
High attrition, only 80 
patients completed all 
measures at all time 
points 
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CDT, MLD, 
intermittent 
pneumatic 
compression, 
compression 
garments, exercise, 
skincare, education 
& self-management 
 
Screening may 
have financial 
benefits, cost per 
year to tx early 
stage BCRL = 
$636.19, late stage 
BCRL = $3124.92 
Passik & 
McDonald,  
 
1998, 
 
Cancer, 
 
US 
 
 
To identify & 
discuss the 
psychosocial 
impacts of LY 
Non-
systematic 
Review 
Level V 
N/A 
N/A O= Psychological & 
functional 
morbidity, 
predictors of 
psychological & 
functional 
morbidity, as well as 
intervention & 
prevention of LY 
Women w/LY tend 
to have higher 
levels of 
psychological, 
functional, sexual 
& social morbidity 
 
Greater disability is 
reported in women 
who have > pain, 
passive/avoidant 
coping styles, poor 
support systems, & 
LY in dominant 
hand 
 
Tx of LY should 
consider 
psychological well-
being (counseling, 
support groups, 
role playing, 
behavioral 
Limited number of 
references 
 
Minimal intext 
citations, majority of 
them are the authors 
own previous article 
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techniques & 
pharmacology) 
Shah et al., 
 
2012, 
 
Breast Jnl, 
 
US 
To summarize 
recent data on 
BCRL to provide 
recommendations 
to patients & 
health care 
providers 
Non-
systematic 
Review 
Level V 
N/A 
N/A Current trends: 
Dx: CM, VD, self-
assessment, BIS 
perometry 
Tx: compression, 
pharmacology, 
CDT, multi-
modality 
Risk factors: ALND, 
chemotherapy, 
regional node 
irradiation, radiation 
therapy 
 
O= Rates of BCRL, 
Dx of LY, tx of LY, 
risk reduction 
BCRL is more 
prevalent than 
generally thought, 
even after less 
morbid axillary 
surgery is 
performed 
 
BCRL can be 
identified earlier 
w/newer dx tools, 
may be used to 
prevent chronic LY 
 
Assessment aids 
should be used 
before & after 
therapy for all @ 
risk patients 
Data for optimal tx 
strategies are 
limited, but CDT 
had significant 
support 
Brief analyses of the 
literature 
 
Very little mention 
of exercise 
interventions for 
LY, which there 
were some studies 
looking at it during 
this time 
 
 
Outcome : Risk Factors and Models of Care 
O’Toole et 
al., 
 
2013, 
 
Crit Rev 
Oncol 
Hematol, 
 
US 
To emphasize the 
need for more 
Level I evidence 
& suggest a 
surveillance 
program 
Non-
systematic 
Review 
Level V 
N/A 
 
Extensive searching of websites & 
brochures was mentioned 
Tx= Prospective 
surveillance 
approach for early 
detection & 
intervention of LY 
 
O= 
Risk factors: ALND, 
radiation, 
chemotherapy, high 
BMI 
QOL: fear & body 
image 
LY is a major 
concern for BC 
patients, they fear 
its development 
 
Inconsistencies 
regarding 
appropriate timing 
& intervention for 
LY, no standard 
approach to 
measurement 
 
The accuracy of 
websites & 
brochures may 
impact the reliability 
& validity of their 
analysis 
 
Mentioned an 
extensive literature 
search but gave no 
specifics about it 
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Controversies: 
definition of LY, 
measurement 
methods, timing, 
management of LY 
Want to implement 
a prospective 
surveillance 
approach w/ a 
randomized phase 
III trial to provide 
level I evidence for 
early intervention 
of LY 
 
 
 
 
 
 
 
Keeley, V., 
 
2017, 
 
Curr 
Opinon, 
 
UK 
 
 
To focus on 
current & new 
developments that 
are relevant to 
clinical practice 
Non-
systematic 
Review 
Level V 
N/A 
 
N/A O=  
Risk factors 
Early detection & 
intervention 
techniques 
Causes of severe LY 
Common risk 
factors associated 
w/LY were: BMI, 
ALND, > lymph 
node dissection, 
sedentary life styles 
& history of other 
cancers 
 
New possible tx for 
LY include: 
docetaxel, 
lymphaticovenular 
anastomosis, 
liposuction, & 
subcutaneous 
needle drainage 
 
Germ line & 
somatic mutations 
have become 
proposed causes for 
severe LY 
 
There needs to be 
more research on 
new & emerging 
detection & tx of 
LY 
Mainly focused on 
new treatments & 
causes of LY, very 
little discussion on 
trends on detection 
or risk factors 
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Ostby et al., 
 
2014, 
 
Jrnl 
Personalized 
Med, 
 
USA 
To review the 
current research 
& to support the 
need for a BCRL 
surveillance 
program 
Non-
systematic 
Review 
Level V 
Pyramid 
N/A 
N/A O=  
Risk factors 
Forms of tx for LY 
Preventative 
interventions 
Cost of traditional & 
prospective models 
 
Common risk 
factors seen in the 
literature are BMI, 
radiation therapy, 
sedentary lifestyle, 
ALND, BC surgery 
& comorbidities 
 
Txs included 
compression 
bandaging, surgery, 
exercise, as well as 
adjuct therapies 
(CDT, low-level 
laser therapy, 
alternative 
medicine) 
 
A multidisciplinary 
surveillance 
approach should be 
implemented for 
the tx of BCRL 
 
A prospective 
surveillance model 
may cost more 
initially; however, 
it can save money 
in the future & 
could improve 
patient QOL 
Some of the 
references were 16 + 
years old. May need 
to redefine current 
w/ research 
 
 
 
 
 
Gerber et al., 
 
2012, 
 
Cancer, 
 
US 
To review 
healthcare models 
for cancer, 
provide an 
overview of 
current care plans, 
& how to 
incorporate a 
Non-
systematic 
Review 
Level V 
Pyramid 
N/A 
N/a O= Models for 
chronic issues: 
Chronic care model 
& Shared care 
model 
Models for BC: 
Survivorship care 
plans 
Prospective 
surveillance model 
provides many 
elements that are 
mentioned in the 
Institute of 
Medicine’s goals 
 
Very little 
recommendations on 
how to implement 
the prospective 
surveillance model 
 
Integration of the 
prospective 
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prospective 
surveillance 
program into 
cancer tx models 
The health models 
are missing 
elements that the 
prospective 
surveillance model 
can provide 
 
This model needs 
to be integrated 
into current models 
to identify 
impairments sooner 
surveillance model 
was proposed for 
only one type of 
model of care 
(survivorship care) 
 
Very strong survivor 
language, which 
may appear as bias 
towards the 
survivorship model 
Systematic Reviews 
Outcome : Treatments for LY 
Shah et al., 
 
2016, 
 
Cancer Med, 
 
US 
To perform a 
literature review 
regarding early 
detection & 
intervention of 
BCRL 
Literature 
Review 
Level I 
E1/D1/O1 
N = 13 studies. 3 RCTs, 4 
prospective studies & 6 retrospective 
studies 
 
I= Studies in English evaluating 
patients 
treated for breast cancer w/some 
form of early 
LY intervention &/or diagnostic 
assessment 
between 1990 & 2015 
 
E= Were not specified 
Searched Medline & 
Pubmed for articles. 
Search terms & how 
articles were 
evaluated was 
provided  
O= 
Tx: MLD, exercise, 
education, 
physiotherapy, 
surveillance, 
compression sleeves 
Volume changes in 
UE 
Dx: Optoelectronic 
perometry, Dual 
energy x-ray 
absorptiometry, BIS, 
CM were used in the 
various studies 
Some support for 
early LY tx (two 
RCTS) 
There is a need to 
form a surveillance 
program for LY 
management 
 
New diagnostic 
techniques have 
made early 
intervention for LY 
possible 
The RCTs had a 
small sample size 
 
Sensitivity of 
diagnostic tests 
varied 
 
No comparison 
between the models 
(surveillance & 
intervention) 
 
Exclusion criteria 
were not specified 
Stuiver et 
al., 
 
2015, 
 
To assess the 
effectiveness of 
conservative 
interventions for 
preventing LY 
Systematic 
Review 
Level I 
E1 
N= 10 RCTs 
 
I= RCTs that reported 2˚ LY as 
outcome, compared usual tx/placebo 
to conservative tx. 
Tx= Gave data bases 
used for searches, 
Psychinfo, PEDro, 
CENTRAL, 
CINAHL, WHO, 
MEDLINE, 
Conflicting results 
for MLD, no 
conclusions can be 
drawn for its 
effectiveness 
 
# of studies 
reviewed was small 
 
None looked @ 
effectiveness of 
 
 
EMERGING OPPORTUNITIES: LYMPHEDEMA                                                                         34 
 
Cochrane 
Database 
Sys Rev, 
 
Netherlands 
 
 
Studies w/both sexes & all ages, non-
pharmacological/surgical tx 
(exercise, patient education, MLD, 
compression), looked @ LY 
occurrence, QOL, pain, function 
 
E= Trials w/patients w/recurrence, 
surgical/pharmacological 
interventions, lower extremity LY 
 
EMBASE, CBCG. 
The process for 
selecting and 
reviewing articles 
was described 
 
O= Effectiveness of 
conventional tx, 
occurrence of LY in 
UE 
Resistance training 
does not ↑ risk of 
LY 
 
Immediate post-op 
start of shoulder 
exercises leads to 
better function in 
the short term (6 
months) 
compression therapy 
or education 
 
None of the studies 
included 
psychosocial 
morbidity 
(depression/anxiety) 
Overall quality of 
evidence was low, 
due to lack of 
blinding in studies 
 
Definition of LY 
differed amongst the 
studies 
McNeely et 
al., 
 
2010, 
 
Cochrane 
Database of 
Sys Rev, 
 
Canada 
To review RCTs 
that examined the 
effectiveness of 
exercise on 
improving, 
preventing & 
minimizing UE 
dysfunction from 
BC 
Systematic 
Review 
Level I 
E1 
 
N= 24 RCTs 
 
I= RCTs that examine the 
effectiveness & safety of exercise for 
UE dysfunction 
 
E= Exercise studies that included 
cancers other than BC, non RCTs 
Tx= Gave key terms 
used in search. 
Searched PubMed, 
PEDro, Medline, 
Embase, LILACS, 
grey literature, 
SIGLE, reference 
lists of articles 
chosen & Cochrane 
BC group 
specialized register 
 
2 authors screened 
the articles to 
determine if they 
were retained. 3 
authors rated quality 
of studies on a 6-
point scale. 
Performed meta-
analyses when 
possible  
 
Early exercise 
programs in the 
early weeks post-
op were effective 
@ improving 
shoulder flex & abd 
More structured 
post-op exercise 
programs were 
more beneficial 
than usual care 
 
No evidence for ↑ 
risk from exercise 
program 
w/adjuvant tx 
 
3 studies supported 
the use of exercise 
programs post 
cancer tx for QOL 
Authors were not 
able to perform 
meta-analyses on 
every study 
 
Data pooling 
because of outcome 
measures, 
measurement 
methods, & timing 
of measurements in 
chosen articles 
Performed meta-
analyses despite 
inter-study 
heterogeneity 
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O= Early vs delayed 
exercise, exercise vs 
comparison, 
exercise vs 
comparison during 
adjuvant cancer tx, 
exercise vs 
comparison post-tx 
Fu et al., 
 
2014, 
 
Oncol 
Nursing Soc, 
 
US 
To provide 
healthcare 
providers 
w/evidence based-
clinical guidelines 
for current tx of 
LY 
Systematic 
Review 
Level I 
D1 
N= 75 articles, between Jan 2009 & 
Feb 2014 
 
I= Full research report, systematic 
review, guideline or meta-analysis, 
must report results of LY 
measurement, must look at an 
intervention (risk 
reduction/prevention/management), 
study sample must include patient’s 
w/cancer 
 
E= Duplicates, studies that don’t 
meet inclusion criteria, qualitative 
studies, case reports, studies on 
vascular changes, no grey literature, 
non-systematic reviews, 
nonreferenced articles, abstracts, 
review guidelines, dissertations & 
secondary data analysis 
Tx= Gave table of 
key search terms 
used. Searched 
PubMed, CINAHL, 
Medline, Cochrane 
Database, CancerLit 
& National Library 
of Medicines 
 
Each article was 
assessed 
independently by 2 
researchers. Articles 
were categorized 
using ONS PEP 
level of evidence 
 
O= Evidence for 
CDT, compression 
garments/bandages, 
full-body exercise 
The use of 
complete 
decongestive 
therapy & 
compression 
garments had 
support from the 
highest levels of 
evidence 
Exercise, early 
intervention & tx 
are likely to be 
effective 
 
 
Found limited 
articles in other 
areas besides 
complete 
decongestive 
therapy & full body 
exercise (possible 
selection bias) 
 
Little explanation 
for conclusions on 
MLD, pneumatic 
compression, & 
low-level laser 
therapy 
 
 
 
 
Abbreviation Key for Systematic Review Table 
ALND = axillary lymph node biopsy, BC = breast cancer, BCRL= breast cancer related lymphedema, BIS = bioimpedance spectroscopy, BMI = body mass 
index, CDT = complete decongestive therapy, CM = circumferential measures, Dx = diagnosis/diagnostic, E = exclusion, I = inclusion, LY = lymphedema, MLD 
= manual lymph drainage, O = outcomes, QOL = quality of life, Tx = treatment, UE = upper extremity, VD = volume displacement
 
 
 
EMERGING OPPORTUNITIES: LYMPHEDEMA                                                                       36 
 
Summary of Key Findings: 
  
Summary of Experimental Studies 
There is strong evidence that exercise is not contraindicated for clients at risk of 
lymphedema (Anderson et al., 2012; Box et al., 2002; Kilbreath et al., 2012; McNeely 
et al., 2010; Olivera et al., 2014; Stuiver et al., 2015, Thakur et al., 2016; Torres 
Lacomba et al., 2010). Physiotherapy included physical modalities such as massage, 
stretching, and compression sleeves. Exercise included various strength training 
protocols. There is strong evidence that exercise directly following post-op is 
correlated with increased function of the upper extremity for clients at risk of 
lymphedema (Kilbreath et al., 2012; McNeely et al., 2010; Stuiver et al., 2015). 
There is limited evidence that control groups without exercise interventions and 
treatment groups with exercise interventions had similar quality of life outcomes on a 
short-term basis (Anderson et al., 2012, Thakur et al., 2016). 
  
Summary of Outcome Studies 
There is strong evidence that compression sleeves are a safe early intervention for 
treating lymphedema in Stage 0 and Stage 1 (Akita et al., 2017; Kaufman, 2017; Sing 
et al., 2013, Stout et al., 2008). There is some evidence that risk factors for 
lymphedema development/progression included axillary lymph node removal, 
regional nodal irradiation, and increased BMI. There is limited evidence to suggest 
that when clients with lymphedema perform occupation based activities, their social 
relationships, mental health, performance and satisfaction with occupational 
performance improves (Maher & Mendonca, 2017).  
  
Summary of Non-Classifiable Studies 
There is strong evidence to implement a surveillance model to increase early 
detection and early intervention of lymphedema. Three articles do conclude that a 
prospective surveillance model may be more expensive initially, however the long-
term health care costs would be less than current traditional models (Otsby et al., 
2014; Sayegh et al., 2017, Stout et al., 2012). One article suggests that the 
surveillance method can be integrated into the current models of practice (Gerber et 
al., 2012). There is moderate evidence to conclude that BMI, radiation therapy and 
method of surgery were risk factors for developing lymphedema (Keeley et al., 2017, 
Otsby et al., 2014). There is limited evidence to suggest that the psychological and 
psychosocial aspects of lymphedema need to be considered during treatment (Passik 
& McDonald, 1998) as well as that the incidence of lymphedema is much greater 
than previously thought (Shah et al., 2012).  
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Summary of Descriptive Studies 
There is strong evidence that compression sleeves and decongestive therapy will be 
effective in treating lymphedema (Fu et al., 2014). There is moderate evidence that 
exercise and early intervention help prevent the progression of lymphedema (Fu et 
al., 2014). Limited evidence exists that BMI, radiation, and axillary lymph node 
dissection were risk factors for developing lymphedema (Schmitz et al., 2012, Soyder 
et al., 2014).  
  
Implications for Consumers: 
 There is strong evidence that exercise does not increase risk of lymphedema post-op. Also, 
surveillance methods to detect lymphedema at a subclinical stage are supported and should 
be discussed with your oncology provider. It is also important to note that fear of developing 
lymphedema may impact function more than physical limitations caused by the lymphedema.  
  
Implications for Practitioners: 
 Pre-operative measurements and surveillance methods are strongly supported in order to 
implement early intervention practices. There should be awareness around potential risk 
factors and education about signs/symptoms of subclinical lymphedema. Exercise may be 
prescribed with a surveillance approach to verify lymphedema is not developing or 
progressing. This is important because in most cases education alone was not sufficient in 
preventing lymphedema, when compared to treatment groups that received a physical 
modality intervention. Additionally, there is strong evidence that compression garments may 
prevent lymphedema from progressing to an irreversible stage. Furthermore, practitioners 
should consider interventions that may impact psychosocial aspects during lymphedema 
treatment. 
  
Implications for Researchers: 
Quality of life measures should be included in research investigating lymphedema 
management and intervention. Retrospective research of client perspective, e.g, how did they 
feel about interventions they received or the lack of, did they receive education on 
lymphedema management, how accessible was the education., etc. Additionally, more 
research needs to be conducted on lymphedema that is related to other types of cancer and 
impacts the lower extremities.  
  
Bottom Line for Occupational Therapy Practice/ Recommendations for Better Practice: 
 There is no evidence that surveillance methods would be contraindicated for lymphedema 
patients. Additionally, there is some evidence that treating lymphedema at a subclinical 
stage reduces treatment time and inhibits the progression of lymphedema. In conclusion, 
there is potential that surveillance methods, coupled with early intervention, may reduce 
overall healthcare costs and maintain a high quality of life for oncology clients.   
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Involvement Plan 
Introduction 
In our meeting with Heidi Shaffer, OTR/L, MSM, CLT-LANA last semester, we presented 
the results from our CAT table. The table provided the strongest evidence for surveillance 
methods as preventing lymphedema from progressing past Stages 1 and 2. Additionally, there 
was strong evidence for the use of compression garments as an early intervention. Furthermore, 
strong evidence was found to suggest that exercise was not contraindicated for early treatment of 
lymphedema. 
We then discussed how our results applied to Shaffer’s setting. We asked Shaffer if 
MultiCare was moving towards a surveillance method. She reported that they were moving 
towards the implementation of surveillance methods, as supported by the purchase of the L-Dex. 
However, she concluded that a surveillance method has not yet been fully implemented. One 
barrier to the implementation was the time commitment required to create and implement a 
system-wide method. Later, we discussed potential options for knowledge translation. These 
included assisting lymphedema lobbyists to further support advocacy for compression garment 
coverage by Medicare or creating a system that Shaffer could use to track patient outcomes. This 
system could help determine the relationship within MultiCare between time of treatment (Stage 
0, 1, 2), length of treatment, modalities, and progression of lymphedema. Additionally, we 
wanted to track the financial outcomes of early intervention vs. standard practice within the 
MultiCare system. These ideas were discussed with our mentor and our chair and were assessed 
based on the semester time constraint limiting what could realistically be completed. 
In our follow up meeting with Shaffer during spring semester, she suggested knowledge 
translation options that would be most helpful to her. These included submitting our research to 
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the International Lymphoedema Framework Conference, a presentation to her supervisor, and a 
potential presentation to the team of lymphedema specialists at one of their quarterly meetings. 
With the course mentor’s guidance, the authors discussed creating a template for tracking 
outcomes to share with Shaffer, her supervisor, and her team. In conclusion, our knowledge 
translation included submission of an abstract to the International Lymphoedema Framework 
Conference, a verbal presentation to Shaffer and her supervisor and a PowerPoint that was made 
available to the rest of Shaffer’s team and other providers who may be interested in the research. 
We conducted a survey to help evaluate the outcomes of our presentation and the proposed 
tracking outcomes data sheet.  
Context 
Our collaborator is employed by MultiCare which is a nonprofit organization in 
Washington State that is a comprehensive healthcare system. There are currently seven 
MultiCare hospitals centered in the South Sound. Shaffer is employed at the MultiCare Women’s 
Health and Wellness Center, Gig Harbor Medical Park. Oncology services are also available at 
the Gig Harbor location. Having multiple specialties within the same physical location ensures 
greater potential for fluid knowledge translation. 
Shaffer is an OTR/CLT/LANA who supports the philosophy of early intervention in 
lymphedema treatment. She is a part of a lymphedema specialist team. This team is composed of 
OTs and PTs and is supervised by Sherri Olsen, OTD, MBA. Shaffer expressed that Olsen 
actively seeks out information that would impact their client outcomes. Olsen’s desire to support 
best practice of lymphedema treatment supported our knowledge translation outcomes. Shaffer’s 
manager has a greater impact on the MultiCare system and therefore, there was a greater 
potential for dissemination of our research findings. 
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Tasks/Products and Target Dates:  
NOTE: Date change for presentation of findings to supervisor Sherri Olsen, moved the dates for other tasks into late 
March.                            
Task Product (1a-f) Deadline Steps w/ dates to achieve the final 
outcome 
How items were achieved w/dates 
Abstract to International 
Lymphoedema 
Framework 
2/14/18 ●     Determine the requirements for 
submitting abstract (2/11-2/12) 
●     Meet to write up the abstract for 
submission (2/12-2/13) 
●     Submit the abstract (2/14) 
 
●     Abstract was submitted to the International 
Lymphoedema Framework on 2/14/18 
●     Abstract was sent to George and Jenny on 
3/26/18 
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Tracking Outcomes 
Data Sheet 
3/19/18* ●     Create a potential template and 
meet with George/Jenny to discuss 
(3/5/18*) 
●     Send Shaffer potential template 
and discuss how to best implement it 
(3/6/18*) 
●     Work it into the 
presentation/introduce it to the 
lymphedema team (3/19/18*) 
  
●     Draft template for tracking outcomes 
completed on 2/21/18 
●     Meeting w/George to discuss data sheet on 
3/26/18 
●     Finalized outcomes sheet presented to 
Shaffer’s supervisor on 4/6/18 
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Presentation to 
supervision and 
lymphedema team 
  ●     Talk to Shaffer about the logistics 
of the presentation (2/12/18) 
●     Compile the main points of our 
evidence and main topic for in-service 
(3/1/18) 
●     Begin creating a presentation 
(3/2/18) 
●     Provide Shaffer with a draft 
presentation for approval (3/20/18*) 
●     Meet with Shaffer’s supervisor to 
present findings (3/28/18*) 
●     Present findings to lymphedema 
team (4/1/18*) 
●     Survey regarding presentation 
and tracking outcomes data sheet 
(4/2/18) 
●     Email communication about meeting 
logistics sent to Shaffer on 2/21/18 
●     Compiled main points of evidence and 
created draft presentation on 3/19/18 
●     Outcomes survey created on 3/19/18 
●     Meeting w/George to review outcomes 
survey on 3/26/18 
●     Met w/Olsen on 4/6/18 to discuss CAT 
findings. Meeting was moved due to logistical 
reasons and scheduling 
●     Email sent to Olsen w/finalized PowerPoint 
to share w/the lymphedema team as well as 
outcome survey and CAT references on 4/6/18 
*Dates are subject to change until Shaffer confirms date for next team meeting. 
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Activities and Products Completed  
Our knowledge translation consisted of three main components. The first component was 
to submit an abstract explaining our research to a lymphedema conference, per Shaffer’s request. 
Shaffer felt that this was very important and was something she had wanted previous groups to 
do as part of their knowledge translation. When looking for conferences to submit to, we found 
that the Annual Lymphedema Conference was not in session this year. However, the 
International Lymphoedema Framework Conference was taking place this summer in the 
Netherlands. We discussed this option with Shaffer, and she encouraged us to submit an abstract. 
The process for writing and submitting the abstract was challenging. The turn-around time 
between email communications with Shaffer and the deadline for submitting the abstract was 
narrow. Additionally, the time zone difference added extra complications for submission. The 
abstract needed to be 250 words and was to be submitted by February 14th, 2018 at midnight 
Netherlands time. Due to these complications, the abstract was written and submitted to the 
conference without further discussion with our project chair or mentor.  After submitting the 
abstract, we notified the project chair and mentor and discussed the logistics of the situation.  
The second component of our knowledge translation was to create an outcomes data 
tracking sheet to monitor lymphedema client outcomes, and determine the referral process for 
lymphedema clients at MultiCare. In order to create this data sheet, we had to consider the 
pertinent information practicing clinicians would collect from clients and how this information 
would be synthesized and analyzed. A large purpose of the survey was to determine who was 
referring lymphedema clients, when the referral was made, the time between referrals and initial 
occupational therapy evaluations as well as what type of education or treatment was provided to 
the client. The draft template was then presented to both our research chair and mentor for 
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feedback. The final template was presented to Olsen, the supervisor for the lymphedema team at 
MultiCare, during the meeting on April 6th. Olsen commented that one of the other lymphedema 
therapists had developed a similar Excel spreadsheet to compile outcome data at the beginning of 
this year. At the end of the meeting, Olsen commented that she would take this template to that 
therapist and discuss further development of outcomes tracking.  
The final component for our knowledge translation was to present our findings to Olsen, 
Shaffer’s supervisor. The presentation consisted of a condensed form of our CAT table including 
our abstract, an overview of the development of our research question, the summaries of the 
evidence, and the implications of our findings. The PowerPoint was sent to Olsen in advance to 
facilitate an informed discussion rather than a slide-by-slide presentation. During the discussion, 
Olsen appeared to be very open to the ideas presented and interested in what the authors had 
found. She asked us questions regarding the various levels of evidence and recent research. 
While discussing the current referral process for lymphedema clients at MultiCare, Olsen 
reported that there is an oncologist who is referring clients on a regular basis, but that it is 
challenging to get the surgical oncologists to refer clients preoperatively. She commented that a 
lack of preoperative and limited postoperative interactions with clients at risk of lymphedema, is 
the greatest barrier to implementing early intervention strategies. At the end of the presentation, 
we discussed how to best disseminate this information to the MultiCare team. It was determined 
that we would send Olsen a list of our CAT references, our PowerPoint and survey. She would 
then provide that information to the rest of the team.  
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Outcomes and Effectiveness 
Outcomes of the knowledge translation were measured with different tools. The 
effectiveness of our conference submitted abstract could not be evaluated due to its denial into 
the conference. No reviewer feedback was provided upon denial to use as outcome data. Upon 
reflection, the submission of the abstract was measurable as a group learning opportunity. There 
was a short deadline for abstract submission that required quick group collaboration and lack of 
editing or revision from our collaborator, mentor, or chair. Additionally, we submitted the 
abstract with the intent to present comparatively to only submitting as a poster presentation. This 
preference could have impacted the revision for submission into the conference.  
The data sheet we created to track outcomes of lymphedema clients was presented to 
Olsen as a possible way to support the implementation of a surveillance method. She disclosed a 
peer had created an Excel tracking sheet and that she would consult with that individual to 
consider the addition of outcomes we had considered. For example, time between referral date 
and an appointment with a lymphedema therapist.  
The in-service was measured by direct conversation throughout the presentation and a 
follow-up survey that will be collected from Olsen via email. From direct feedback, Olsen 
reported the in-service did provide novel ideas that she was excited to implement. For example, a 
possible video for pre-op education that would support a surveillance method treatment 
approach. In the follow-up survey, Olsen indicated that she did learn new information including 
the role of surveillance methods in the MultiCare system. Additionally, she found the most 
pertinent and impactful information in our discussion to be about using technology for educating 
clients as well as the reinforcement that exercise is supported for daily function in clients at risk 
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of developing lymphedema. Furthermore, Olsen commented that future UPS research groups 
could assist in creating client education videos.  
Evaluation of the Overall Process of Project 
Our research group was particularly excited for our research topic especially because we 
had been exposed to Shaffer and her clinical reasoning during a guest lecture in biomechanics. 
We originally wanted to follow-up on last year’s project, however after meeting with Shaffer our 
research took a different direction while still supporting Shaffer’s current needs. Research for our 
topic was fairly accessible, as related to breast cancer. Originally, with Shaffer’s guidance we did 
want to include research of various cancer, however the research emphasized breast cancer even 
without using breast cancer as a search term. One minor challenge faced during the research 
phase was observing the trends in lymphedema research. Our research question specifically 
focused on early intervention however, trends in lymphedema research included many risk factor 
studies. Having a support team of faculty to problem solve with was supportive in addressing this 
challenge. Through this project we were able to engage with clinicians and potentially set-up 
future student research groups to contribute to lobbying for lymphedema management, 
specifically supporting treatment that would decrease the progression of lymphedema to an 
irreversible stage.  
At the beginning of the process our group of three established communication around 
roles we would each fill to facilitate the efficiency of the group as we moved through the year 
long process. Setting these roles ahead of time, in addition to open communication throughout 
the process facilitated completing the parts of the project in a timely manner. Additionally, our 
meetings were tracked on a data sheet to support team member accountability and as a reflection 
of how much time we were committing to the project.  
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We feel accomplished in completing our CAT, especially after our meeting with Olsen. 
Seeing all of our hard work being well received and valued by a practicing clinician who has 
potential to effect change on a systems level, was rewarding and motivating. This project was 
eye-opening to the vast opportunities we will have as future occupational therapists and we could 
not be more excited to engage in our new role as entry-level practitioners.  
Recommendations for the Future  
One of our findings suggested the potential for implementation of surveillance methods 
as it is not contraindicated by available research. This lead to our group developing an outcomes 
tracking worksheet which could be utilized to understand trends in lymphedema referrals over 
time. Of particular interest, is tracking elements which may support wider use of preventive 
lymphedema intervention as opposed to treating lymphedema once it has already progressed past 
Stage 1. During the meeting with Olsen it was discovered there is currently a physical therapist 
in oncology at MultiCare who has been informally tracking clinical outcomes since the start of 
2018. The value of clinical outcomes tracking is frequently overlooked because of time 
constraints evident in medical workplaces. Future student research could be directed towards 
supporting widespread implementation of an outcomes tracking system within a large scale 
medical network like MultiCare. If students were to dedicate research in this direction they may 
be able to access the outcomes data currently being tracked by the physical therapist mentioned 
above. Furthermore, research groups may be able to analyze this data in effort to extrapolate 
meaning from the synthesis of currently tracked outcomes data.  
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Appendix A 
Outcomes Data Tracking Sheet 
Oncology referral date: 
 
Referring physician/location: 
 
__PCP  __Surgeon  __Oncology  
__Other:________    
 
Oncology appointment date: 
 
 
Referral date to OT: 
 
OT appointment date: 
 
Bioimpedance Score  
Intake: 
Stage of Lymphedema: 
0   1    2   3 
 
Follow-up 1: 
Stage of Lymphedema: 
0   1    2   3 
 
Follow-up 2: 
Stage of Lymphedema: 
0   1    2   3 
 
Follow-up 3: 
Stage of Lymphedema: 
0   1    2   3 
 
OT treatment plan: 
□Education 
□Compression garment: OTC/Custom 
□Home program  
 __Occupation  __Self-massage 
__ROM (Passive / Active) __ 
Strengthening  
□Other:______________ 
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Appendix B 
Knowledge Translation Follow-up Survey 
1. Was there new information presented to you today? 
Y/N If yes, please describe. 
 
 
 
 
2. What was the most pertinent information presented today? 
 
 
 
3. Is there potential for this information to be impactful to the MultiCare system? 
If yes, how so? What are potential support/barriers? 
 
 
 
 
 
4. Has a past research group from the University of Puget Sound created an impactful 
change within the MultiCare organization? 
Y / N Briefly describe 
 
 
 
 
 
5. What next steps could student researchers take to support the implementation or 
translation of this information? 
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